{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:42:29Z","timestamp":1790700149896,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Yangtze River Delta Digital Trunk Line Qingpu District Science and Technology Development Fund Project","award":["QKY2023-21"],"award-info":[{"award-number":["QKY2023-21"]}]},{"name":"Bengbu Medical College Natural Science Fund Project","award":["2022byzd161"],"award-info":[{"award-number":["2022byzd161"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objectives<\/jats:title>\n            <jats:p>Traumatic brain injury (TBI) is a critical public health issue with high mortality and disability rates. Current diagnostic tools lack sensitivity and specificity, under-scoring the need for novel biomarkers. This study aimed to evaluate the clinical utility of NLRP3, ASC, and Caspase-1 as biomarkers for assessing TBI severity and prognosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A prospective cohort of 89 patients with moderate-to-severe TBI was studied. Blood and cerebrospinal fluid (CSF) samples were collected for four consecutive days post-injury. Levels of NLRP3, ASC, and Caspase-1 were measured using enzyme-linked immunosorbent as-say (ELISA). Statistical analyses, including ROC curve analysis, were conducted to assess their predictive performance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>NLRP3, ASC, and Caspase-1 levels in both serum and CSF were significantly elevated in TBI patients, with higher levels correlating with greater injury severity. ROC analysis revealed that CSF biomarkers, particularly NLRP3, demonstrated superior predictive value. CSF NLRP3 levels on days 1, 2, and 4 had AUC values of 0.9871, 0.9466, and 0.8967, respectively. Dynamic changes in these biomarkers over time provided insights into disease progression and prognosis. Serum markers, while less predictive than CSF, were also effective for assessing injury severity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>NLRP3, ASC, and Caspase-1 are promising biomarkers for evaluating TBI severity and predicting outcomes. Their dynamic monitoring may improve clinical management and in-form therapeutic strategies. Future research should validate these findings in larger cohorts and explore interventions targeting these inflammatory pathways.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s13760-025-02761-8","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:26:35Z","timestamp":1741685195000},"page":"745-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Detection of NLRP3, ASC, and Caspase-1 in serum and cerebrospinal fluid of traumatic brain injury patients: implications for short-term prognosis"],"prefix":"10.1007","volume":"125","author":[{"given":"Adilijiang","family":"Aihemaitiniyazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"key":"2761_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","volume":"80","author":"N Carney","year":"2017","unstructured":"Carney N, Totten AM, O\u2019Reilly C et al (2017) Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery 80:6\u201315. https:\/\/doi.org\/10.1227\/NEU.0000000000001432","journal-title":"Neurosurgery"},{"key":"2761_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/PCC.0000000000001736","volume":"20","author":"PM Kochanek","year":"2019","unstructured":"Kochanek PM, Tasker RC, Carney N et al (2019) Guidelines for the management of pediatric severe traumatic brain injury, third edition: Update of the brain trauma foundation guidelines, executive summary. Pediatr Crit Care Med 20:280\u2013289. https:\/\/doi.org\/10.1097\/PCC.0000000000001736","journal-title":"Pediatr Crit Care Med"},{"key":"2761_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002331","volume":"14","author":"M Majdan","year":"2017","unstructured":"Majdan M, Plancikova D, Maas A et al (2017) Years of life lost due to traumatic brain injury in europe: A cross-sectional analysis of 16 countries. PLoS Med 14:e1002331. https:\/\/doi.org\/10.1371\/journal.pmed.1002331","journal-title":"PLoS Med"},{"key":"2761_CR4","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/S1474-4422(18)30469-1","volume":"18","author":"J-Y Jiang","year":"2019","unstructured":"Jiang J-Y, Gao G-Y, Feng J-F et al (2019) Traumatic brain injury in China. Lancet Neurol 18:286\u2013295. https:\/\/doi.org\/10.1016\/S1474-4422(18)30469-1","journal-title":"Lancet Neurol"},{"key":"2761_CR5","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S1474-4422(20)30182-4","volume":"19","author":"G Gao","year":"2020","unstructured":"Gao G, Wu X, Feng J et al (2020) Clinical characteristics and outcomes in patients with traumatic brain injury in China: A prospective, multicentre, longitudinal, observational study. Lancet Neurol 19:670\u2013677. https:\/\/doi.org\/10.1016\/S1474-4422(20)30182-4","journal-title":"Lancet Neurol"},{"key":"2761_CR6","doi-asserted-by":"publisher","first-page":"6204","DOI":"10.3390\/ijms21176204","volume":"21","author":"N Irrera","year":"2020","unstructured":"Irrera N, Russo M, Pallio G et al (2020) The role of NLRP3 inflammasome in the pathogenesis of traumatic brain injury. Int J Mol Sci 21:6204. https:\/\/doi.org\/10.3390\/ijms21176204","journal-title":"Int J Mol Sci"},{"key":"2761_CR7","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S1474-4422(13)70073-5","volume":"12","author":"J Verch\u00e8re","year":"2013","unstructured":"Verch\u00e8re J, Blanot S, Vergnaud E et al (2013) Mortality in severe traumatic brain injury. Lancet Neurol 12:426\u2013427. https:\/\/doi.org\/10.1016\/S1474-4422(13)70073-5","journal-title":"Lancet Neurol"},{"key":"2761_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40035-017-0088-2","volume":"6","author":"M Cruz-Haces","year":"2017","unstructured":"Cruz-Haces M, Tang J, Acosta G et al (2017) Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases. Transl Neurodegener 6:20. https:\/\/doi.org\/10.1186\/s40035-017-0088-2","journal-title":"Transl Neurodegener"},{"key":"2761_CR9","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.injury.2021.01.042","volume":"52","author":"GF Miller","year":"2021","unstructured":"Miller GF, Daugherty J, Waltzman D, Sarmiento K (2021) Predictors of traumatic brain injury morbidity and mortality: Examination of data from the national trauma data bank: predictors of TBI morbidity & mortality. Injury 52:1138\u20131144. https:\/\/doi.org\/10.1016\/j.injury.2021.01.042","journal-title":"Injury"},{"key":"2761_CR10","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210040","volume":"104","author":"DP Whitehouse","year":"2025","unstructured":"Whitehouse DP, Wilson L, Czeiter E et al (2025) Association of blood-based biomarkers and 6-month patient-reported outcomes in patients with mild TBI: A CENTER-TBI analysis. Neurology 104:e210040. https:\/\/doi.org\/10.1212\/WNL.0000000000210040","journal-title":"Neurology"},{"key":"2761_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.neubiorev.2021.08.029","volume":"130","author":"ME Huibregtse","year":"2021","unstructured":"Huibregtse ME, Bazarian JJ, Shultz SR, Kawata K (2021) The biological significance and clinical utility of emerging blood biomarkers for traumatic brain injury. Neurosci Biobehav Rev 130:433\u2013447. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.08.029","journal-title":"Neurosci Biobehav Rev"},{"key":"2761_CR12","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40035-024-00457-2","volume":"13","author":"Z Huang","year":"2024","unstructured":"Huang Z, Xu P, Hess DC, Zhang Q (2024) Cellular senescence as a key contributor to secondary neurodegeneration in traumatic brain injury and stroke. Transl Neurodegener 13:61. https:\/\/doi.org\/10.1186\/s40035-024-00457-2","journal-title":"Transl Neurodegener"},{"key":"2761_CR13","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s11910-024-01382-7","volume":"24","author":"E C\u00e1ceres","year":"2024","unstructured":"C\u00e1ceres E, Olivella JC, Di Napoli M et al (2024) Immune response in traumatic brain injury. Curr Neurol Neurosci Rep 24:593\u2013609. https:\/\/doi.org\/10.1007\/s11910-024-01382-7","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2761_CR14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/biom14101283","volume":"14","author":"TV Butkova","year":"2024","unstructured":"Butkova TV, Malsagova KA, Nakhod VI et al (2024) Candidate molecular biomarkers of traumatic brain injury: A systematic review. Biomolecules 14:1283. https:\/\/doi.org\/10.3390\/biom14101283","journal-title":"Biomolecules"},{"key":"2761_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115718","volume":"259","author":"MG Shaik","year":"2023","unstructured":"Shaik MG, Joshi SV, Akunuri R et al (2023) Small molecule inhibitors of NLRP3 inflammasome and GSK-3\u03b2 in the management of traumatic brain injury: A review. Eur J Med Chem 259:115718. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115718","journal-title":"Eur J Med Chem"},{"key":"2761_CR16","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70009","volume":"30","author":"W Chen","year":"2024","unstructured":"Chen W, Wang Z, Ye G et al (2024) Changes of NLRP3 in serum and cerebrospinal fluid of patients after moderate to severe traumatic brain injury and their predictive values for prognosis. CNS Neurosci Ther 30:e70009. https:\/\/doi.org\/10.1111\/cns.70009","journal-title":"CNS Neurosci Ther"},{"key":"2761_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s11596-016-1628-1","volume":"36","author":"X Wei","year":"2016","unstructured":"Wei X, Hu C-C, Zhang Y-L et al (2016) Telmisartan reduced cerebral edema by inhibiting NLRP3 inflammasome in mice with cold brain injury. J Huazhong Univ Sci Technolog Med Sci 36:576\u2013583. https:\/\/doi.org\/10.1007\/s11596-016-1628-1","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"2761_CR18","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fphar.2017.00459","volume":"8","author":"N Irrera","year":"2017","unstructured":"Irrera N, Pizzino G, Cal\u00f2 M et al (2017) Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury. Front Pharmacol 8:459. https:\/\/doi.org\/10.3389\/fphar.2017.00459","journal-title":"Front Pharmacol"},{"key":"2761_CR19","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1089\/neu.2017.5344","volume":"35","author":"S Ismael","year":"2018","unstructured":"Ismael S, Nasoohi S, Ishrat T (2018) MCC950, the selective inhibitor of nucleotide oligomerization domain-like receptor protein-3 inflammasome, protects mice against traumatic brain injury. J Neurotrauma 35:1294\u20131303. https:\/\/doi.org\/10.1089\/neu.2017.5344","journal-title":"J Neurotrauma"},{"key":"2761_CR20","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.brainres.2019.01.005","volume":"1710","author":"Y Chen","year":"2019","unstructured":"Chen Y, Meng J, Xu Q et al (2019) Rapamycin improves the neuroprotection effect of inhibition of NLRP3 inflammasome activation after TBI. Brain Res 1710:163\u2013172. https:\/\/doi.org\/10.1016\/j.brainres.2019.01.005","journal-title":"Brain Res"},{"key":"2761_CR21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.nbd.2018.05.016","volume":"117","author":"X Xu","year":"2018","unstructured":"Xu X, Yin D, Ren H et al (2018) Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiol Dis 117:15\u201327. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.016","journal-title":"Neurobiol Dis"},{"key":"2761_CR22","first-page":"2883","volume":"13","author":"Q Li","year":"2021","unstructured":"Li Q, Zhao Z, Si K et al (2021) Correlation between the levels of NLRP3, hcy, IL-1\u03b2, IL-18 and the prognosis in patients with hemorrhagic stroke. Am J Transl Res 13:2883\u20132890","journal-title":"Am J Transl Res"},{"key":"2761_CR23","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1007\/s10072-020-04949-7","volume":"42","author":"Z-J Zhou","year":"2021","unstructured":"Zhou Z-J, Xia P (2021) Elevated levels of NLRP3 inflammasome in serum of patients with chronic inflammatory demyelinating polyradiculoneuropathy are associated with disease severity. Neurol Sci 42:3383\u20133387. https:\/\/doi.org\/10.1007\/s10072-020-04949-7","journal-title":"Neurol Sci"},{"key":"2761_CR24","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/jamasurg.2014.13","volume":"149","author":"K Salottolo","year":"2014","unstructured":"Salottolo K, Levy AS, Slone DS et al (2014) The effect of age on glasgow coma scale score in patients with traumatic brain injury. JAMA Surg 149:727\u2013734. https:\/\/doi.org\/10.1001\/jamasurg.2014.13","journal-title":"JAMA Surg"},{"key":"2761_CR25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9315","volume":"12","author":"S Podkovik","year":"2020","unstructured":"Podkovik S, Kashyap S, Wiginton J et al (2020) Comparison of ventricular and lumbar cerebrospinal fluid composition. Cureus 12:e9315. https:\/\/doi.org\/10.7759\/cureus.9315","journal-title":"Cureus"},{"key":"2761_CR26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12987-022-00405-0","volume":"20","author":"N Rostgaard","year":"2023","unstructured":"Rostgaard N, Olsen MH, Ottenheijm M et al (2023) Differential proteomic profile of lumbar and ventricular cerebrospinal fluid. Fluids Barriers CNS 20:6. https:\/\/doi.org\/10.1186\/s12987-022-00405-0","journal-title":"Fluids Barriers CNS"},{"key":"2761_CR27","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.expneurol.2017.01.005","volume":"290","author":"C Lin","year":"2017","unstructured":"Lin C, Chao H, Li Z et al (2017) Omega-3 fatty acids regulate NLRP3 inflammasome activation and prevent behavior deficits after traumatic brain injury. Exp Neurol 290:115\u2013122. https:\/\/doi.org\/10.1016\/j.expneurol.2017.01.005","journal-title":"Exp Neurol"},{"key":"2761_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12028-017-0378-7","volume":"27","author":"JS Wallisch","year":"2017","unstructured":"Wallisch JS, Simon DW, Bay\u0131r H et al (2017) Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children. Neurocrit Care 27:44\u201350. https:\/\/doi.org\/10.1007\/s12028-017-0378-7","journal-title":"Neurocrit Care"},{"key":"2761_CR29","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1007\/s11064-013-1115-z","volume":"38","author":"H-D Liu","year":"2013","unstructured":"Liu H-D, Li W, Chen Z-R et al (2013) Expression of the NLRP3 inflammasome in cerebral cortex after traumatic brain injury in a rat model. Neurochem Res 38:2072\u20132083. https:\/\/doi.org\/10.1007\/s11064-013-1115-z","journal-title":"Neurochem Res"},{"key":"2761_CR30","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1089\/neu.2017.5530","volume":"35","author":"SW Lee","year":"2018","unstructured":"Lee SW, Gajavelli S, Spurlock MS et al (2018) Microglial inflammasome activation in penetrating ballistic-like brain injury. J Neurotrauma 35:1681\u20131693. https:\/\/doi.org\/10.1089\/neu.2017.5530","journal-title":"J Neurotrauma"},{"key":"2761_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12974-019-1423-6","volume":"16","author":"SW Lee","year":"2019","unstructured":"Lee SW, de Rivero Vaccari JP, Truettner JS et al (2019) The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury. J Neuroinflammation 16:27. https:\/\/doi.org\/10.1186\/s12974-019-1423-6","journal-title":"J Neuroinflammation"},{"key":"2761_CR32","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1007\/s10753-016-0446-8","volume":"39","author":"J Ma","year":"2016","unstructured":"Ma J, Xiao W, Wang J et al (2016) Propofol inhibits NLRP3 inflammasome and attenuates blast-induced traumatic brain injury in rats. Inflammation 39:2094\u20132103. https:\/\/doi.org\/10.1007\/s10753-016-0446-8","journal-title":"Inflammation"},{"key":"2761_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","volume":"11","author":"R Zhou","year":"2010","unstructured":"Zhou R, Tardivel A, Thorens B et al (2010) Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136\u2013140. https:\/\/doi.org\/10.1038\/ni.1831","journal-title":"Nat Immunol"},{"key":"2761_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon F, P\u00e9trilli V, Mayor A et al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241. https:\/\/doi.org\/10.1038\/nature04516","journal-title":"Nature"},{"key":"2761_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10072-014-1909-z","volume":"36","author":"Z Li","year":"2015","unstructured":"Li Z, Tian F, Shao Z et al (2015) Expression and clinical significance of non-phagocytic cell oxidase 2 and 4 after human traumatic brain injury. Neurol Sci 36:61\u201371. https:\/\/doi.org\/10.1007\/s10072-014-1909-z","journal-title":"Neurol Sci"},{"key":"2761_CR36","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.3892\/mmr.2017.7079","volume":"16","author":"H Qian","year":"2017","unstructured":"Qian H, Li Q, Shi W (2017) Hyperbaric oxygen alleviates the activation of NLRP-3-inflammasomes in traumatic brain injury. Mol Med Rep 16:3922\u20133928. https:\/\/doi.org\/10.3892\/mmr.2017.7079","journal-title":"Mol Med Rep"},{"key":"2761_CR37","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nri2725","volume":"10","author":"J Tschopp","year":"2010","unstructured":"Tschopp J, Schroder K (2010) NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production? Nat Rev Immunol 10:210\u2013215. https:\/\/doi.org\/10.1038\/nri2725","journal-title":"Nat Rev Immunol"},{"key":"2761_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210128","volume":"13","author":"N Kerr","year":"2018","unstructured":"Kerr N, Lee SW, Perez-Barcena J et al (2018) Inflammasome proteins as biomarkers of traumatic brain injury. PLoS ONE 13:e0210128. https:\/\/doi.org\/10.1371\/journal.pone.0210128","journal-title":"PLoS ONE"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02761-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-025-02761-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02761-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T06:14:37Z","timestamp":1748672077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-025-02761-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2761"],"URL":"https:\/\/doi.org\/10.1007\/s13760-025-02761-8","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"23 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}